Furthermore, pinpointing additional functional mechanisms modulating causal common variants at the APOE region and elucidating their roles in AD susceptibility might contribute to delineating therapeutic strategies for controlling this important susceptibility factor. This evidence concerns the gene APOE and Alzheimer disease.